Skip to content
Business Times – Lifestyle
Author:
Dyne Therapeutics, Inc.
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 29, 2026
Dyne Therapeutics Announces Participation at 2026 Academy of Managed Care Pharmacy (AMCP) Conference to Begin Shaping Access in US for Potential Neuromuscular Medicines
April 1, 2026
←
Previous Page
1
2